SUBSCRIBE
SUBSCRIBE

Tennessee

Business partners shaking hands after closing a deal
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products
November 7, 2024
 · 
4 min read
Press Releases
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
October 31, 2024
 · 
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
October 25, 2024
 · 
3 min read
Press Releases
Evergreen Nephrology Appoints John Donlan as CEO
October 23, 2024
 · 
4 min read
Business
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
October 21, 2024
 · 
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024
 · 
3 min read
Press Releases
Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
October 10, 2024
 · 
3 min read
Press Releases
DAXOR’S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL ’24
October 9, 2024
 · 
3 min read
Press Releases
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
 · 
2 min read
Press Releases
New CPAP Device with Much Lower Pressure Found as Effective as Traditional CPAP and Reported to be More Comfortable
October 8, 2024
 · 
5 min read
Press Releases
Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer
October 8, 2024
 · 
3 min read
Press Releases
Harrow Relaunches TRIESENCE®
October 3, 2024
 · 
7 min read
Press Releases
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
September 30, 2024
 · 
4 min read
Press Releases
Currax Pharmaceuticals Unveils New Disease Awareness Campaign to “Quiet the Food Noise,” a Key Barrier for Individuals Seeking Weight Loss
September 24, 2024
 · 
2 min read
Press Releases
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
September 19, 2024
 · 
3 min read
Press Releases
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
September 13, 2024
 · 
4 min read
Press Releases
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
September 5, 2024
 · 
3 min read
Business
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
 · 
3 min read
Press Releases
Navigating Cancer Accelerates Investments to Enhance Care Management Platform for Providers and Patients
September 3, 2024
 · 
3 min read
News
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
August 27, 2024
 · 
3 min read
Load More